Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in CORBUS PHARMACEUTICALS HLDGS
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 1,224 shares of CRBP (CORBUS PHARMACEUTICALS HLDGS), worth $11,493 as of 2026-Q1. The position was increased (+30.4% shares).
Current Value
$11,493
Current Shares
1,224
Total Value Change
+$3,850
Total Shares Change
+285
Other major holders of CRBP: BNP PARIBAS FINANCIAL MARKETS, Kestra Advisory Services, LLC
Increased |
| 1,224 |
+30.4% |
| $11,493 |
| 0.0% |
| $8.21 |
15 |
| 2025-Q4 | New | 939 | - | $7,643 | 0.0% | $8.01 | 25 |